In chronic atrial fibrillation (AF) model, gap junctions were down‐regulated and Cx43 was significantly decreased, then treatment of metformin could reverse this change by increasing the expression of ZO‐1 and promoting the interaction of Cx43 with ZO‐1, alleviating the vulnerability of AF.109. The gene discussed is TJP1; the disease is atrial fibrillation.